Navigation Links
New Health Corp. Introduces Heart Savior(TM), the Ultimate Natural Heart Health Product
Date:12/7/2007

Lowering Cholesterol is only part of the battle in fighting heart disease,

says New Health Corp. CEO Gary Stanton.

MELBOURNE, Fla., Dec. 7 /PRNewswire/ -- Heart Savior (http://www.heartsavior.com) was designed for the many causes of heart disease all in one Natural product. Lowering unhealthy cholesterol levels is a good start, but there are other factors to consider including the build up of plaque in the arteries and the heart muscle itself. The formulators of Heart Savior considered all these factors when designing Heart Savior making it the most comprehensive heart health product available.

The Medical Doctors and research scientists that developed Heart Savior identified the 7 most powerful natural ingredients for heart health. Not only has it been clinically proven to lower LDL ("bad") cholesterol and triglycerides, but Heart Savior also includes Co-Q10, anti-oxidants and other anti inflammatory ingredients which help reduce the build up of plaque in the arteries. Co-Q10 is known to decrease with age and to be low in people with chronic diseases such as heart conditions and diabetes. Some prescription drugs may also lower Co-Q10.

The all-new Heart Savior formula created by New Health Corp., offers an all-natural approach, free of the dangerous side effects that may accompany prescription cholesterol medications. In a recent clinical study, the Heart Savior formula was found to be effective in improving several aspects of blood lipids. This study showed Heart Savior lowered LDL (bad) cholesterol by up to 34%, VLDL up to 76%, triglycerides up to 76% and total cholesterol up to 28%, while helping to improve circulatory health.

"As a Cardiac Surgeon, I'm often hesitant to prescribe the common cholesterol lowering pharmaceutical drugs because of potential negative side effects like weakness, nausea, liver damage, and destruction of muscle tissue. Heart Savior
'/>"/>

SOURCE New Health Corp.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Air pollution linked to cardiovascular risk indices in healthy young adults
4. More proof needed of safety and quality of electronic personal health records
5. Health care incentive model offers collaborative approach
6. Loneliness is bad for your health
7. Mailman School of Public Health study examines link between racial discrimination and substance use
8. Green Tea May Brew Up Healthier Skin
9. For Health Info, Women Often Turn to the Web
10. Record Number of Americans Lack Health Insurance
11. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...t of laws was initiated by Quebec Health Minister ...becers the option of private health-care insurance...tially struck down Quebec's ban on private insuran...ad failed to prove its ban on private health insur...
...bumani Ramadoss Friday warned of "strong action" a...elhi's All India Institute of Medical Sciences// (...s institution into a "political hub". "Some people...ical hub and action will be taken against them whe...
...rofessor Jonas Frisén who is at the Karolinska Ins...t which new cells are being produced// by individu...as published in the journal Cell. The research fee... drugs for diseases such as neurological disorders...
...ublished a report www.bmj.com which speaks of the ... born to women with diabetes. // They have caution... of women suffering diabetes shows no improvement....after birth (perinatal mortality) and congenital a...
Other Medicine News:Health News:Quebecers To Choose Private Health-Care Insurance 2Health News:Mechanism of Stem Cell Regulation Identified 2Health News:Diabetic women may suffer a complicated pregnancy 2
(Date:9/4/2008)...., Sept. 4 /- Southern Research Insti...of Health (NIH) has selected,the organization to p...,Probe Production Center Network (MLPCN). The MLPC...f the Molecular Libraries Program which is,designe...ledge of the human,genome and validate future targ...
(Date:9/4/2008)...land, September 4 /- Axentis Pharma A...ss the safety and tolerability,of a new therapeuti...y,infection in cystic fibrosis patients. The new f... to be delivered directly to the site of,infection...cts of two,different doses of the new drug. Initia...
(Date:9/4/2008)...onstrates potent antiviral activity and favorable ...AMBRIDGE, Mass., Sept. 4 /-...biopharmaceutical company engaged,in the discovery...an viral,and other infectious diseases, today anno...tudy evaluating IDX899, a non-nucleoside reverse,t...
(Date:9/4/2008)...ts Remain on Schedule with Two Abstracts Accepted ...ase in November 2008, BRIDGEWATER, N.J., Sept. 4 ...specialty pharmaceutical company focused on the tr...oday announced the appointment of,Peter L. Garramb...ter Garrambone,s career includes more than 50 phar...
Breaking Medicine Technology:Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2We Care Health Services Inc partners with IgeaCare Systems Inc to deliver Healthanywhere 28TM 29 for Chronic Disease Management in Canada 13806 1We Care Health Services Inc partners with IgeaCare Systems Inc to deliver Healthanywhere 28TM 29 for Chronic Disease Management in Canada 13806 2We Care Health Services Inc partners with IgeaCare Systems Inc to deliver Healthanywhere 28TM 29 for Chronic Disease Management in Canada 13806 3New stem cell technique improves genetic alteration 13803 1New stem cell technique improves genetic alteration 13803 2New stem cell technique improves genetic alteration 13803 3IPC The Hospitalist Company Inc to Report Fourth Quarter and Year End 2007 Financial Results 13800 1IPC The Hospitalist Company Inc to Report Fourth Quarter and Year End 2007 Financial Results 13800 2iCAD to Feature New Products and Capabilities at European Congress of Radiology 3794 1iCAD to Feature New Products and Capabilities at European Congress of Radiology 3794 2iCAD to Feature New Products and Capabilities at European Congress of Radiology 3794 3
...lif., April 16, 2007 /PRNewswire-FirstCall/ -- Kos...nical data on,KOS-1803, a next-generation epothilo... a favorable pharmacokinetic and safety,profile in...r,models. KOS-1803 has been chemically engineered ...hich has been shown in models to,result in excelle...
...tion Demonstrated in Lung and Colorectal Cancers, ...ll/ --,EntreMed, Inc. , a clinical-stage pharmaceu...tment of cancer and inflammatory diseases,announc... tubulin,inhibitor compounds. The data were presen...tion for Cancer Research (AACR) Annual,Meeting in ...
Other Medicine Technology:Kosan Presents Preclinical Antitumor and Safety Data On,Next-Generation Epothilone KOS-1803 at AACR 2Kosan Presents Preclinical Antitumor and Safety Data On,Next-Generation Epothilone KOS-1803 at AACR 3EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in,Preclinical Models 2EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in,Preclinical Models 3EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in,Preclinical Models 4
Clearview C. Diff A is a one-step test for the direct qualitative detection of Clostridium difficile toxin A from fecal samples.
ThyroTest TSH is a rapid, qualitative test for hypothyroidism screening in adults.
...est is one of the easiest tests to run on the mark...s with no hands-on time. Critical care instruction...aving the pediatrician's office and valuable infor... to help control the spread of RSV infections. Now...
The BinaxNOW Influenza A & B Test simplifies rapid influenza testing. The easiest flu test on the market just got easier with accurate differentiation between influenza A and influenza B using one si
Medicine Products: